In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

India's CRDMO sector, projected to hit $22-25 billion by 2035, is rapidly expanding due to cost advantages and quick startup ...

Discovering ultra-conserved elements in the genome and their role in limiting protein production in mice testes.

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...

A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...

India holds a two to three per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a global leader.

The scientists demonstrate that it is possible to specifically deliver the treatment to the muscle stem cells, avoiding ...

As part of this partnership, Lucence’s molecular testing solutions will be incorporated into Agilus’ oncology diagnostics ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...